Quintiles can dramatically reduce the time and cost of running prospective observational studies using MediGuard, our direct connection with over 2.5M patients from around the world.
Collecting prospective observational data can be time and cost intensive, even when your study protocol is very simple. The process of identifying, contracting and motivating investigators to recruit patients is not always so simple, and often results in hidden costs and delays that can compromise the most straightforward projects.
To overcome these investigator-centric problems, Quintiles has created MediGuard, the largest direct-to-patient research platform in the world. Through MediGuard’s direct access to over 2.5M clinically profiled and engaged patients, Quintiles can now work directly with patients to capture the clinical data, patient reported outcomes and lab data you need to complete your observational research in record time.